vimarsana.com

Page 3 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் மன ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How an app is helping women self-diagnose perinatal depression

Antibody Mediated Prevention (AMP) trials data published by the i New England Journal of Medicine /i

Antibody Mediated Prevention (AMP) trials data published by the New England Journal of Medicine Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains Public Relations Pacific LLC  E-Mail SEATTLE - (EMBARGOED UNTIL MARCH 17, 2021, AT 5 P.M. ET) - The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains to the 30% of strains that were sensitive to the bnAb. This finding was seen both in Sub-Saharan Africa and the U.S. and South America. VRCO1 did not prevent the acquisition of HIV to strains that were resistant to the bNAb. As the resistant strains constituted nearly 70% of the circulating strains in these regions, there was no difference noted between the VRC01 arms and placebo arm in terms of overall prevention of HIV acquisition. The sensitivity to bNAbs was assessed by a laborat

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.